BRIEF published on 05/30/2025 at 18:19, 1 year 4 months ago Emova Group publie son rapport annuel de durabilité 2024 EMOVA GROUP Réduction Carbone Fleurs Françaises RSE Durabilité
REGULATED PRESS RELEASE published on 05/30/2025 at 18:14, 1 year 4 months ago Emova Group - Rapport annuel de Durabilité 23/24 EMOVA Group publie son rapport annuel de durabilité pour l'exercice clos au 30 septembre 2024, mettant en avant ses engagements environnementaux et sociaux. Consultez le rapport sur www.emova-group.com EMOVA GROUP Durabilité Rapport Annuel Engagements Sociaux Engagements Environnementaux
BRIEF published on 01/31/2025 at 20:37, 1 year 8 months ago Emova Group: Results for the first quarter of 2024/2025 E-commerce EMOVA GROUP Expansion Turnover Flower Heap
BRIEF published on 01/31/2025 at 20:37, 1 year 8 months ago Emova Group : Résultats du 1er trimestre 2024/2025 E-commerce EMOVA GROUP Chiffre D'affaires Expansion Monceau Fleurs
BRIEF published on 01/31/2025 at 20:34, 1 year 8 months ago EMOVA Group: Annual results 2023/2024 EMOVA GROUP Financial Results Turnover Strategy 2025 Franchises
BRIEF published on 01/31/2025 at 20:34, 1 year 8 months ago EMOVA Group : Résultats annuels 2023/2024 EMOVA GROUP Chiffre D'affaires Résultats Financiers Stratégie 2025 Franchises
REGULATED PRESS RELEASE published on 01/31/2025 at 20:32, 1 year 8 months ago EMOVA GROUP - Volume d'affaires T1 2024-25 Emova Group annonce une croissance de 5,7% de son chiffre d'affaires au 1er trimestre 2024/2025 avec des ouvertures de magasins et une forte progression digitale. Objectifs financiers confirmés EMOVA GROUP Chiffre D'affaires Croissance Objectifs Financiers Ouvertures De Magasins
REGULATED PRESS RELEASE published on 01/31/2025 at 20:29, 1 year 8 months ago Emova Group - Résultats annuels 2023/24 Emova Group annonce un chiffre d'affaires de 28 M€ pour l'exercice 2023/2024 avec une marge d'EBITDA ajustée de 24,60%. Perspectives ambitieuses pour le futur EMOVA GROUP Chiffre D'affaires Perspectives EBITDA Ajusté Réseau De Ventes
BRIEF published on 11/14/2024 at 18:06, 1 year 11 months ago Emova Group : Performance et défis du T4 2023/2024 EMOVA GROUP Stratégie Financière Jeux Olympiques Franchises Volume D'affaires
BRIEF published on 11/14/2024 at 18:06, 1 year 11 months ago Emova Group: Performance and challenges for Q4 2023/2024 EMOVA GROUP Business Volume Financial Strategy Olympic Games Franchises
Published on 10/23/2026 at 16:00, 1 hour 32 minutes ago Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/23/2026 at 13:23, 4 hours 9 minutes ago Slam Mobilizes Drill Team to Moose Lake, Intersecting Broad Zones of Brecciated and Altered Rock With Visible Stibnite Along the Moose Lake Fault Zone
Published on 10/23/2026 at 13:00, 4 hours 32 minutes ago First Canadian Graphite Inc. Announces Flow-Through Financing
Published on 10/23/2026 at 13:00, 4 hours 32 minutes ago First Canadian Graphite Inc. annonce un financement accréditif
Published on 10/23/2026 at 02:20, 15 hours 12 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/23/2026 at 17:11, 21 minutes ago Original-Research: Serviceware SE (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 10/23/2026 at 16:40, 52 minutes ago THE POWER OF WILL: A SERIES OF CONVERSATIONS ABOUT DETERMINATION AND INDIVIDUALITY
Published on 10/23/2026 at 16:25, 1 hour 7 minutes ago Lassa introduces new winter tyre Wintus 3 for light commercial vehicles
Published on 10/23/2026 at 07:00, 10 hours 32 minutes ago Safran publie son chiffre d’affaires du 3e trimestre 2026
Published on 10/22/2026 at 18:00, 23 hours 32 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 23 hours 32 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 23 hours 32 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics